Saham Teknologi Nikkei Terangkat Sentimen Wall Street
Pasar saham Asia sebagian besar bergerak naik sedikit pada perdagangan Rabu (13/03/2024), karena saham-saham teknologi utama mengikuti kenaikan Wall Street
MODERNA, PFIZER: vaccine status update
Diperbarui • 2020-09-16
In one of the recent interviews, Donald Trump claimed that the US pharma sector is three to four weeks away from the vaccine for the Covid-19. He mentioned Pfizer (the primary candidate to win the vaccine race, competes mainly with Moderna) and Johnson&Johnson (never appeared in the media headlines as vaccine developer until now). Very possibly, that is another pre-election move to spark the interest of the audience. On the other hand, he is not the only country leader who “reports” that the vaccine is coming: China did the same recently, not to mention Russia. So it appears that the world pharma sector is indeed somewhere close to the final stages of the vaccine. What does it mean? Those companies that manage to develop the vaccine first will probably see the cost of their shares rise in value. Let’s have a look at the main candidates and our technical targets to prepare for that.
Pfizer: knocking the rooftop
On the below chart, the technical layout is pretty clear. Pfizer’s stock price descended from the heights of above $40 where it used to be during 2018-2019 to the depths of $30 during the crisis. Since March, it made two marches upwards, and we seem to witness the third one now. However, in none of those marches it managed to break the roof of $39. Now, as it is approaching this resistance, so is nearing the verbal deadline of 3-4 weeks announced by the US President. If there are positive signs of the vaccine development as the days go by, we are likely to see this resistance broken. In this scenario, the closest target for the stock price will be $41. Otherwise, is Pfizer doesn’t manage to deliver on time, the stock price is likely to bounce downwards from the resistance to make another dip to the trend bottom.
Moderna: shrugging off old trends
Moderna’s stock price used to go downwards in an equilateral channel since July. The last day’s candlestick in the chart below is clearly of that trend so it can now be discarded as a possible reference for levels. In the meantime, there is another channel where Moderna used to trade: a sideways trend with the bottom at $57 and the upper border at $68. The latter is the local resistance that is being tested by the price currently. If Moderna manages to cross it with confidence, it will likely aim at a tactical high of $95 as the far horizon – that is, if it is announced as a successful vaccine developer.
Menyerupai
Nikkei Sentuh Rekor Tinggi, Terdorong Penguatan Wall Street
Pasar saham Asia sebagian besar terkoreksi pada perdagangan Jumat (01/03/2024), kecuali indeks Nikkei Jepang menuju rekor tinggi, didukung oleh penguatan di Wall Street.. Indeks S&P 500 dan Nasdaq ditutup pada rekor tertinggi
Indeks Nasdaq Akan Terangkat Saham NVIDIA
Pasar saham Asia bergerak bervariasi pada perdagangan Kamis (22/02/2024), mengikuti sinyal positif dari Nvidia, saham favorit AI, Risalah pertemuan Federal Reserve (FOMC minutes) pada bulan Januari menunjukkan sebagian besar pembuat kebijakan khawatir terhadap risiko
Berita terbaru
Yen Terus Terpuruk Mendekati Level Terendah Multi-Dekade
Yen Jepang gagal memikat para investor pada perdagangan Selasa (02/04/2024) meski ada peluang atas kemungkinan intervensi dan..Sentimen penghindaran risiko masih berpotensi memberikan kekuatan pada safe-haven
Sanggupkan Emas Berlama-lama di Puncak?
XAUUSD naik ke rekor tertinggi baru pada perdagangan Senin (01/04/2024), di tengah meningkatnya spekulasi penurunan suku bunga..melanjutkan kenaikan kuat minggu lalu hingga membentuk level puncak baru sepanjang masa
Sebagian Pasar Masih Libur, Yen Stabil di Bawah 152
Pasar saham Asia sebagian masih libur dan sebagian lagi menguat pada perdagangan Senin (01/04/2024), karena optimisme data pabrikan Tiongkok mendukung..potensi intervensi otoritas Jepang terhadap yen Jepang diperkirakan berada di zona 152 – 155 yen.
